tradingkey.logo

Boston Scientific Corp

BSX
查看詳細走勢圖
91.950USD
-0.630-0.68%
交易中 美東報價延遲15分鐘
136.30B總市值
48.71本益比TTM

Boston Scientific Corp

91.950
-0.630-0.68%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.68%

5天

-5.71%

1月

-10.46%

6月

-7.81%

今年開始到現在

+2.94%

1年

+2.04%

查看詳細走勢圖

TradingKey Boston Scientific Corp股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Boston Scientific Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名20/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價125.29。中期看,股價處於平穩狀態。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Boston Scientific Corp評分

相關信息

行業排名
20 / 208
全市場排名
81 / 4592
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 36 分析師
買入
評級
125.291
目標均價
+33.52%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Boston Scientific Corp亮點

亮點風險
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
業績高增長
公司營業收入穩步增長,連續3年增長32.05%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入16.75B美元
估值低估
公司最新PE估值49.04,處於3年歷史低位
機構減倉
最新機構持股1.40B股,環比減少0.03%
HACAX持倉
明星投資者HACAX持倉,最新持倉21.57K股

Boston Scientific Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Boston Scientific Corp簡介

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
公司代碼BSX
公司Boston Scientific Corp
CEOMahoney (Michael F)
網址https://www.bostonscientific.com/en-US/Home.html

常見問題

Boston Scientific Corp(BSX)的當前股價是多少?

Boston Scientific Corp(BSX)的當前股價是 91.950。

Boston Scientific Corp 的股票代碼是什麼?

Boston Scientific Corp的股票代碼是BSX。

Boston Scientific Corp股票的52週最高點是多少?

Boston Scientific Corp股票的52週最高點是109.500。

Boston Scientific Corp股票的52週最低點是多少?

Boston Scientific Corp股票的52週最低點是85.980。

Boston Scientific Corp的市值是多少?

Boston Scientific Corp的市值是136.30B。

Boston Scientific Corp的淨利潤是多少?

Boston Scientific Corp的淨利潤為1.85B。

現在Boston Scientific Corp(BSX)的股票是買入、持有還是賣出?

根據分析師評級,Boston Scientific Corp(BSX)的總體評級為買入,目標價格為125.291。

Boston Scientific Corp(BSX)股票的每股收益(EPS TTM)是多少

Boston Scientific Corp(BSX)股票的每股收益(EPS TTM)是1.888。
KeyAI